Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000725214 | SCV000242411 | likely benign | not provided | 2021-05-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 18308289) |
Genetic Services Laboratory, |
RCV000188787 | SCV000248789 | likely benign | not specified | 2020-09-07 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000725214 | SCV000335038 | uncertain significance | not provided | 2017-11-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001085976 | SCV000557612 | likely benign | Progressive myoclonic epilepsy | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000725214 | SCV000615020 | benign | not provided | 2019-06-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311280 | SCV000846619 | likely benign | Inborn genetic diseases | 2018-08-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomics, |
RCV000768072 | SCV000898943 | uncertain significance | Action myoclonus-renal failure syndrome | 2021-03-30 | criteria provided, single submitter | clinical testing | SCARB2 NM_005506 exon 4 p.Val149Met (c.445G>A): This variant has not been reported in the literature but is present in 0.3% (437/126510) of European alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs147159813). This variant is present in ClinVar (Variation ID:206701). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Prevention |
RCV003907663 | SCV004722200 | likely benign | SCARB2-related condition | 2021-02-10 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV000188787 | SCV001931659 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000188787 | SCV001968589 | benign | not specified | no assertion criteria provided | clinical testing |